Send me a link:

*Text messaging rates may apply.

 Dow Down1.62% Nasdaq Down1.85%

More On PROT



News & Info


Analyst Coverage



Proteonomix, Inc. (PROT)

-Other OTC
0.02 0.00(0.00%) Jul 28
ProfileGet Profile for:
Proteonomix, Inc.
145 Highview Terrace
Hawthorne, NJ 07506
United States - Map
Phone: 973-949-4193
Fax: 973-949-4196

Index Membership:N/A
Full Time Employees:N/A

Business Summary 

Proteonomix, Inc., a biotechnology company, focuses on developing therapeutics based upon the use of human cells and their derivatives. The company’s products include Proteoderm, an anti-aging skin cream based on a proprietary and patented matrix of proteins that reduce wrinkles; UMK-121, a treatment for liver disease using a combination of two or three approved drugs to mobilize particular bone marrow stem cells; and StromaCel, a treatment for cardiac patients within two weeks of a myocardial infarction using stem cells derived from donor bone marrow and administered through IV solution to repair heart tissue. Its products also comprise NC-138, a proprietary matrix of proteins, which act on the skin to enhance activities that reduce wrinkles. The company was formerly known as National Stem Cell Holding, Inc. and changed its name to Proteonomix, Inc. in August 2008. Proteonomix, Inc. was incorporated in 1995 and is based in Hawthorne, New Jersey.

Key Statistics

Company Websites 
Home Page
Search Yahoo! for:
More on Proteonomix, Inc.

Key Executives 
Mr. Michael Cohen , 47
Founder, Chairman, Chief Exec. Officer, Pres and Chief Operating Officer
Mr. Steven Byle J.D., 46
Chief Technology Officer and Director
Dr. Ian McNiece Ph.D., 60
Chief Scientific Officer, Vice-Pres of Scientific Devel., Member of Scientific Advisory Board and Member of The Board of Directors
Mr. Roger L. Fidler Esq., 63
Gen. Counsel, Treasurer and Director
Mr. Jason B. Isaacs , 42
Amounts are as of Dec 31, 2011 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc.Exercised is the value of options exercised during the fiscal year.
Currency in USD.
View Insiders